Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
Liposomes represent a versatile drug formulation approach e.g. for improving the water-solubility of poorly soluble drugs but also to achieve drug targeting and controlled release. For the latter applications it is essential that the drug remains associated with the liposomal carrier during transit in the vascular bed. A range of in vitro test methods has been suggested over the years for prediction of the release of drug from liposomal carriers. The majority of these fail to give a realistic prediction for poorly water-soluble drugs due to the intrinsic tendency of such compounds to remain associated with liposome bilayers even upon extensive dilution. Upon i.v. injection, in contrast, rapid drug loss often occurs due to drug transfer from the liposomal carriers to endogenous lipophilic sinks such as lipoproteins, plasma proteins or membranes of red blood cells and endothelial cells. Here we report on the application of a recently introduced in vitro predictive drug transfer assay based on incubation of the liposomal drug carrier with large multilamellar liposomes, the latter serving as a biomimetic model sink, using flow field-flow fractionation as a tool to separate the two types of liposomes. By quantifying the amount of drug remaining associated with the liposomal drug carrier as well as that transferred to the acceptor liposomes at distinct times of incubation, both the kinetics of drug transfer and release to the water phase could be established for the model drug p-THPP (5,10,15,20-tetrakis(4-hydroxyphenyl)21H,23H-porphine). p-THPP is structurally similar to temoporfin, a photosensitizer which is under clinical evaluation in a liposomal formulation. Mechanistic insights were gained by varying the donor-to-acceptor lipid mass ratio, size and lamellarity of the liposomes. Drug transfer kinetics from one liposome to another was found rate determining as compared to redistribution from the outermost to the inner concentric bilayers, such that the overall process could be adequately described by a single 1st order kinetic model. By varying the donor-to-acceptor lipid mass ratio in the range 1:1 to 1:10, a correlation was established between donor-to-acceptor-lipid mass ratio and transfer kinetics, which is regarded essential for scaling to physiological lipid mass ratios. By applying the assay to a series of structurally related model compounds of different bilayer affinity, transfer and release kinetics were established over the whole expected range of liposome bilayer associated drugs in terms of water solubility and lipophilicity. A very rapid transfer and considerable release from liposomes to the water phase was observed for the more water-soluble compounds Sudan II (clogP 5.45) and Sudan III (clogP 6.83). For the more lipophilic compounds, the rate of transfer from the donor liposomes followed the rank order Sudan IV (fastest)>Oil Red O>Sudan Black>p-THPP (slowest). For an equimolar donor-to-acceptor lipid mass ratio, half-lifes of transfer in the range of 12min (Sudan IV) up to 1.5h (p-THPP) were determined. In essence, the results presented here allow for both, mechanistic insights and predictions of drug loss from liposomal carriers upon exposure to biological sinks, which appear more realistic than the commonly employed in vitro release tests.
University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Campusvej 55, DK-5230 Odense, Denmark.
Askell Hvid
AH
Hinna
Aker Biomarine Antarctic AS, Oksenøyveien 10, P.O Box 496, NO-1327 Lysaker, Norway; Institute for Energy Technology, Isotope laboratories, Instituttveien 18, P.O. Box 40, NO-2027 Kjeller, Norway.
Stefan
S
Hupfeld
University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Campusvej 55, DK-5230 Odense, Denmark.
Judith
J
Kuntsche
University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Campusvej 55, DK-5230 Odense, Denmark.
Annette
A
Bauer-Brandl
University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Campusvej 55, DK-5230 Odense, Denmark. Electronic address: mmb@sdu.dk.
Martin
M
Brandl
D004396:Coloring Agents / Q000008:administration & dosage / Q000737:chemistry; D065546:Drug Liberation; D031521:Fractionation, Field Flow; D007700:Kinetics; D008055:Lipids / Q000737:chemistry; D008081:Liposomes; D011166:Porphyrins / Q000008:administration & dosage / Q000737:chemistry; D012995:Solubility
D004396:Coloring Agents; D008055:Lipids; D008081:Liposomes; D011166:Porphyrins; C481734:meso-tetra-(4-hydroxyphenyl)porphyrin
Drug leakage; Drug release; Drug transfer; Liposome; Phospholipid